Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer (vol 37, pg 424, 2003)

被引:0
作者
Fang, CY [1 ]
Miller, SM [1 ]
Malick, J [1 ]
Babb, J [1 ]
Engstrom, PF [1 ]
Daly, MB [1 ]
机构
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
关键词
D O I
10.1016/j.ypmed.2004.03.009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:222 / 222
页数:1
相关论文
共 50 条
  • [41] Ovarian cancer among 8005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2
    Ingham, Sarah Louise
    Warwick, Jane
    Buchan, Iain
    Sahin, Sarah
    O'Hara, Catherine
    Moran, Anthony
    Howell, Anthony
    Evans, D. Gareth
    JOURNAL OF MEDICAL GENETICS, 2013, 50 (06) : 368 - 372
  • [42] Trends in incidence of breast cancer among women under 40 in seven European countries: A GRELL cooperative study (vol 37, pg 544, 2013)
    Leclere, Brice
    Molinie, Florence
    Tretarre, Brigitte
    Stracci, Fabrizio
    Daubisse-Marliac, Laetitia
    Colonna, Marc
    CANCER EPIDEMIOLOGY, 2014, 38 (01) : 106 - 106
  • [43] Risk Information Exposure and Direct-to-Consumer Genetic Testing for BRCA Mutations among Women with a Personal or Family History of Breast or Ovarian Cancer
    Gray, Stacy W.
    O'Grady, Cristin
    Karp, Lauren
    Smith, Daniel
    Schwartz, J. Sanford
    Hornik, Robert C.
    Armstrong, Katrina
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (04) : 1303 - 1311
  • [44] Exploring the relationships among spiritual well-being, quality of life, and psychosocial adjustment in women with breast cancer (vol 8, pg 429, 1999)
    Cotton
    Fitzpatrick
    Levine
    Targ
    Dold
    PSYCHO-ONCOLOGY, 2000, 9 (01) : 89 - 89
  • [46] ABCB1 (MDR1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy (vol 14, pg 5594, 2008)
    Johnatty, S. E.
    Beesley, J.
    Paul, J.
    Fereday, S.
    Spurdle, A. B.
    Webb, P. M.
    CLINICAL CANCER RESEARCH, 2012, 18 (01) : 319 - 320
  • [47] RETRACTION: Clinical significance and expression of the PRSS3 and Wiskott-Aldrich syndrome protein family verprolin-homologous protein 1 for the early detection of epithelial ovarian cancer (Retraction of Vol 37, Pg 6769, 2016)
    Azizmohammadi, Sima
    Safari, Aghdas
    Seifoleslami, Mehri
    Rabati, Rahman Ghaffarzadegan
    Mohammadi, Mohsen
    Yahaghi, Hamid
    Azizmohammadi, Susan
    TUMOR BIOLOGY, 2016, 37 (12) : 16399 - 16399
  • [48] Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21-to 55-year-old women
    Palomaki, GE
    McClain, MR
    Steinort, K
    Sifri, R
    LoPresti, L
    Haddow, JE
    GENETICS IN MEDICINE, 2006, 8 (03) : 161 - 168
  • [49] Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial (vol 361, pg 2099, 2003)
    Ledermann, JA
    Colombo, N
    du Bois, A
    Torri, V
    Floriani, I
    Qian, W
    Adams, HP
    Parmar, MKB
    Collins, S
    Wheeler, S
    Poli, D
    Santillo, M
    Buda, A
    Elser, G
    Schantl, P
    LANCET, 2003, 362 (9394) : 1504 - 1504
  • [50] Evaluating the Acceptance and Usability of an App Promoting Weight Gain Prevention and Healthy Behaviors Among Young Women With a Family History of Breast Cancer: Protocol for an Observational Study ( vol 12, e47765 , 2022 )
    Pegington, Mary
    Davies, Alan
    Mueller, Julia
    Cholerton, Rachel
    Howell, Anthony
    Evans, D. Gareth
    Howell, Sacha J.
    French, David P.
    Harvie, Michelle
    JMIR RESEARCH PROTOCOLS, 2023, 12